Background: |
Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. |
Applications: |
WB |
Name of antibody: |
SMAD2(Ab-465) |
Immunogen: |
Synthesized peptide derived from C-terminal of human Smad2. |
Full name: |
SMAD family member 2 |
Synonyms: |
JV18; MADH2; MADR2; JV18-1; hMAD-2; hSMAD2 |
SwissProt: |
Q15796 |
WB Predicted band size: |
52 kDa |
WB Positive control: |
293 cells, JurKat cells, HepG2 cells and K562 cells lysates |
WB Recommended dilution: |
500-3000 |